These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9295828)

  • 1. An evaluation of empiric vs. nomogram-based dosing of heparin in an intensive care unit.
    Brown G; Dodek P
    Crit Care Med; 1997 Sep; 25(9):1534-8. PubMed ID: 9295828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial.
    Raschke RA; Reilly BM; Guidry JR; Fontana JR; Srinivas S
    Ann Intern Med; 1993 Nov; 119(9):874-81. PubMed ID: 8214998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a Calculation-Free Weight-Based Unfractionated Heparin Nomogram With Anti-Xa Level Monitoring Compared With Activated Partial Thromboplastin Time.
    Kindelin NM; Anthes AM; Providence SM; Zhao X; Aspinall SL
    Ann Pharmacother; 2021 May; 55(5):575-583. PubMed ID: 32964730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients.
    Marotti SB; Barras M; Kirkpatrick C
    Ther Drug Monit; 2015 Feb; 37(1):33-9. PubMed ID: 24831654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke.
    Toth C; Voll C
    Stroke; 2002 Mar; 33(3):670-4. PubMed ID: 11872885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications.
    Floroff CK; Palm NM; Steinberg DH; Powers ER; Wiggins BS
    Pharmacotherapy; 2017 Apr; 37(4):393-400. PubMed ID: 28107569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reevaluation of a weight-based heparin dosing nomogram: is institution-specific modification necessary?
    Schlicht JR; Sunyecz L; Weber RJ; Tabas GH; Smith RE
    Ann Pharmacother; 1997 Dec; 31(12):1454-9. PubMed ID: 9416380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.
    Ansara AJ; Arif S; Warhurst RD
    Ann Pharmacother; 2009 Jan; 43(1):9-18. PubMed ID: 19126826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the standard pediatric unfractionated heparin dosing protocol.
    Al Obary EE; Al-Jazairi AS; Zaghloul IM; Saleh MM; Al Musa AS; Al-Halees Z
    Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):153-9. PubMed ID: 22499962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing and testing a system to improve the quality of heparin anticoagulation in patients with acute cardiac syndromes.
    Mungall D; Lord M; Cason S; Treadwell P; Williams D; Tedrick D
    Am J Cardiol; 1998 Sep; 82(5):574-9. PubMed ID: 9732882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redesign of a weight-based heparin protocol for improved outcomes in a community hospital.
    Stahl KL; Pollard DL
    J Nurs Care Qual; 2003; 18(3):193-201. PubMed ID: 12856903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation.
    Shalansky KF; FitzGerald JM; Sunderji R; Traboulay SJ; O'Malley B; McCarron BI; Naiman S
    Pharmacotherapy; 1996; 16(6):1076-84. PubMed ID: 8947981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an intravenous heparin nomogram in a coronary care unit.
    Paradiso-Hardy FL; Cheung B; Geerts WH
    Can J Cardiol; 1996 Sep; 12(9):802-8. PubMed ID: 8842133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ; Rosenberg AF; Winterstein AG; Harris NS; Johns TE; Zumberg MS
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfractionated heparin dosing for therapeutic anticoagulation in critically ill obese adults.
    Hohner EM; Kruer RM; Gilmore VT; Streiff M; Gibbs H
    J Crit Care; 2015 Apr; 30(2):395-9. PubMed ID: 25534987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight based heparin dosing for thromboembolic disease is associated with earlier anticoagulation in surgical patients.
    Levine AR; Laliberte B; Lin H; Stan K; Ladha KS; Kaafarani HM; Lee J
    Int J Surg; 2014 Dec; 12(12):1416-9. PubMed ID: 25448664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight-based heparin dosing: clinical response and resource utilization.
    Lackie CL; Luzier AB; Donovan JA; Feras HI; Forrest A
    Clin Ther; 1998; 20(4):699-710. PubMed ID: 9737830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed efficient anticoagulation with heparin in patients with a weight of 110 kg and more treated for acute coronary syndrome.
    Joncas SX; Poirier P; Ardilouze JL; Carrier N; Fayad T; Farand P
    Obesity (Silver Spring); 2013 Sep; 21(9):1753-8. PubMed ID: 23404940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature.
    Myzienski AE; Lutz MF; Smythe MA
    Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of unfractionated heparin using activated partial thromboplastin time: an assessment of the current nomogram and analysis according to age.
    Kim JS; Lee HJ; Sung JD; Kim HJ; Lee SY; Kim JS
    Clin Appl Thromb Hemost; 2014 Oct; 20(7):723-8. PubMed ID: 23615295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.